Does sage help with memory, hot flashes and blood sugar?

Sage (Salvia officinalis) belongs to the mint family (Lamiaceae) and has been used medicinally across Mediterranean, Middle Eastern, and European traditions for thousands of years. Modern phytochemistry has identified the compounds responsible for its wide range of effects.

Key active compounds:

• Rosmarinic acid — a powerful polyphenol with anti-inflammatory, antioxidant, and neuroprotective activity
• Carnosic acid and carnosol — terpenoids with antioxidant and antimicrobial properties; also potent Nrf2 activators that upregulate the body's own antioxidant defenses
• 1,8-cineole (eucalyptol) — the dominant volatile compound; crosses the blood-brain barrier and inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine
• Alpha- and beta-thujone — volatile terpenes contributing to sage's distinctive aroma; responsible for traditional cautions against excessive use
• Ursolic acid and oleanolic acid — triterpenes with anti-inflammatory, hypoglycemic, and liver-protective effects

Memory and cognition is the best-documented benefit in human clinical trials. The mechanism centers on acetylcholinesterase inhibition — sage compounds slow the breakdown of acetylcholine, the neurotransmitter critical for memory formation and attention. This is the same mechanism targeted by pharmaceutical Alzheimer's drugs like donepezil, though sage works more gently and through multiple parallel pathways. A double-blind crossover study in healthy older adults (>65 years) found that a 333 mg dose of sage extract significantly enhanced secondary memory performance compared to placebo at all testing time points. Lower and higher doses were less effective, suggesting an optimal range¹. A later randomized placebo-controlled parallel groups trial in 94 adults (ages 30–60) found that sage extract produced consistent, significant improvements in working memory, Corsi Blocks (spatial memory), and name-to-face recall — effects that were present both acutely (same day) and grew stronger after 29 days of supplementation, suggesting cumulative benefits².

Menopausal hot flashes: Sage has estrogenic activity through weak phytoestrogen compounds that bind estrogen receptors without the risks associated with pharmaceutical hormone replacement. It also contains compounds that reduce activity in thermoregulatory pathways in the hypothalamus, directly dampening the neurological trigger for hot flashes. An open clinical trial with 71 menopausal women (at least 5 hot flashes daily) treated with a once-daily tablet of fresh sage for 8 weeks found that mild hot flashes decreased by 46%, moderate by 62%, severe by 79%, and very severe hot flashes by 100%³. A 2023 systematic review and meta-analysis of placebo-controlled trials found fewer hot flashes with Salvia officinalis than with placebo, but no significant change in their severity⁴.

Blood sugar regulation: Sage appears to act similarly to metformin in animal models, activating insulin-sensitizing pathways in liver and muscle cells. In humans, a 3-month randomized placebo-controlled trial in 80 hyperlipidemic type 2 diabetic patients found that sage leaf extract (500 mg three times daily) significantly reduced fasting blood glucose, HbA1c, total cholesterol, triglycerides, and LDL while increasing HDL compared to placebo⁵. A 2022 meta-analysis confirmed these glycemic improvements across pooled clinical trials⁶.

Antimicrobial and antioxidant activity: Sage essential oil shows activity against a broad range of bacterial strains and fungi including Candida albicans. The high antioxidant content — particularly rosmarinic acid — places sage among the highest antioxidant herbs tested. Carnosic acid activates the Nrf2 pathway, a master switch that turns on the body's own production of glutathione and other protective enzymes⁷.

Forms and dosing:

• Fresh or dried leaf tea: 1–2 tsp dried sage steeped in hot water for 5–10 minutes, 1–3 times daily
• Standardized extract: 300–600 mg daily (the dose range used in most cognitive and menopause trials)
• Culinary use: Adds meaningful polyphenols to diet, though lower dose than extracts

Safety notes: Sage contains thujone, which is neurotoxic and can cause seizures at high doses^8,9. The European Medicines Agency's herbal committee requires sage-leaf medicines to state their thujone content and keep daily exposure below 6 mg, prefers low-thujone plants, and concluded that the benefits of swallowing sage essential oil do not outweigh its risks, because the oil is so rich in thujone^8,9. Sage oil in amounts equal to more than 15 g of leaf has caused a racing heart, vertigo and seizures⁸, and a newborn and a toddler had tonic-clonic seizures after accidental exposure to sage oil¹⁰. Tea is far milder: sage tea infusions averaged 4.4 mg of thujone per litre for food teas and 11.3 mg per litre for medicinal teas, and on average 3 to 6 cups a day stayed below toxicological thresholds¹¹. The committee does not recommend medicinal sage for anyone under 18, or during pregnancy and breastfeeding, where its safety has not been established⁸. Because thujone can trigger seizures, people with epilepsy should talk to their doctor before using sage extracts or drinking sage tea regularly. People on diabetes or blood pressure medications should monitor levels, as sage may enhance their effects.

Cross-reference: See our lemon balm and bacopa monnieri pages for other herbs with cognitive-enhancing evidence. For menopausal support, see our shatavari and maca root pages.

Scholey et al. (2008) — Sage extract and memory in healthy older adults¹

This double-blind, placebo-controlled crossover trial enrolled 20 volunteers over age 65 (mean age 72.95). Participants received four different doses of sage extract (167, 333, 666, and 1332 mg) and placebo in a randomized order, with 7-day washout periods between visits. The primary outcome measure was the Cognitive Drug Research computerized assessment battery, covering attention, working memory, and secondary memory. The 333 mg dose produced the most robust results: significant enhancement of secondary memory performance at all testing time points (1, 2.5, 4, and 6 hours post-dose) compared to placebo. The 167 mg dose showed weaker effects, while the higher doses (666 and 1332 mg) paradoxically showed diminished effects compared to the middle dose, consistent with an inverted-U dose-response curve common in cognition research. The mechanism was attributed to cholinesterase inhibition confirmed in in vitro assays of the same extract. This study was important for establishing that sage's cognitive effects in animal models translated to humans.

Wightman et al. (2021) — Acute and chronic cognitive effects in adults²

This randomized, double-blind, placebo-controlled, parallel groups study enrolled 94 healthy participants (25 male, 69 female, ages 30–60) over 29 days, with neuropsychological assessments at baseline, day 1 (acute), and day 29 (chronic). The sage treatment group (n=45) and placebo group (n=49) completed the study. The sage combination extract produced consistent, statistically significant improvements on working memory and accuracy measures: Corsi Blocks (spatial working memory), Numeric Working Memory, and Name to Face Recall tasks. Notably, the effects were present acutely (day 1) and grew stronger after 29 days of daily use, suggesting that the cognitive benefits accumulate over time rather than being a single-dose effect. The authors proposed that chronic cholinesterase inhibition combined with the antioxidant and anti-inflammatory effects of rosmarinic acid and other polyphenols produces progressive neuroprotective benefits. Effect sizes were moderate (Cohen's d approximately 0.4–0.6 on key measures), which is meaningful for a dietary supplement in a healthy population.

Bommer, Klein, and Suter (2011) — Sage for menopausal hot flushes³

This multicenter open clinical trial conducted across eight Swiss general practices enrolled 71 postmenopausal women (mean age 56.4 years, menopausal for at least 12 months, experiencing at least 5 hot flashes daily). All participants received one tablet of fresh sage leaves daily for 8 weeks following a 1-week baseline observation period. The primary endpoint was change in hot flash frequency and severity. Results were striking: by week 4, total hot flash intensity had decreased by 50%; by week 8 the decrease reached 64%. Breaking down by severity — mild hot flashes decreased by 46%, moderate by 62%, severe by 79%, and very severe hot flashes by 100% over the full 8 weeks. Night sweats and other menopausal complaints also improved. The tolerability profile was excellent, with no serious adverse events. The limitation of this study is the open-label design without a placebo control, meaning a placebo effect cannot be fully excluded. However, the magnitude and dose-gradient of the response across severity categories suggests a genuine pharmacological effect beyond expectation for placebo.

Moradi et al. (2023) — Meta-analysis of sage for hot flashes⁴

This systematic review and meta-analysis searched PubMed, Web of Science, Cochrane, Scopus, SID, and Magiran, identifying 4 eligible randomized controlled trials including 310 postmenopausal women. Meta-analysis found that Salvia officinalis significantly reduced the frequency of hot flashes compared to placebo (pooled effect statistically significant). The effect on severity did not reach significance across pooled trials, possibly due to heterogeneity in severity measurement methods. The authors recommended Salvia officinalis as a candidate for inclusion in menopausal management guidelines, noting its favorable safety profile. Limitations include the small number of eligible trials and heterogeneity in preparation, dose, and duration.

Kianbakht and Dabaghian (2013) — Glycemic control RCT⁵

This double-blind randomized placebo-controlled trial enrolled 80 hyperlipidemic type 2 diabetic patients who were randomized to sage leaf extract (500 mg capsule three times daily = 1,500 mg/day) or matched placebo for 3 months. At endpoint, the sage group showed significant reductions compared to placebo in: fasting blood glucose (-18 mg/dL vs. placebo), HbA1c (-0.9% vs. placebo), total cholesterol (-23 mg/dL), triglycerides (-28 mg/dL), and LDL-C (-21 mg/dL), while HDL-C increased (+4 mg/dL). No significant adverse effects were reported. The magnitude of HbA1c reduction (approximately 0.9%) is clinically relevant and comparable to the effects of some pharmaceutical antidiabetic adjuncts. The study population was patients not at glycemic targets despite existing treatment, meaning sage was studied as an add-on rather than as monotherapy.

Abdollahi et al. (2022) — Meta-analysis of glycemic effects⁶

This systematic review and meta-analysis in the Journal of Complementary and Integrative Medicine pooled data from three studies in diabetic patients. Meta-analysis results showed statistically significant reductions in fasting blood sugar (MD: −31.15 mg/dL; 95% CI: −37.56 to −24.73; p<0.00001) and HbA1c (MD: −0.94%; 95% CI: −1.25 to −0.63; p<0.00001) in patients receiving Salvia officinalis. Total cholesterol also improved significantly. The authors noted that the number of included articles was small and recommended that stronger clinical trials be conducted. The effect size for HbA1c reduction, while promising, falls in the range that would be considered moderate by conventional clinical standards.

Safety: thujone and regulatory guidance^8,9,10,11

The European Union herbal monograph on sage leaf (2016) lists sage tea, extracts and tinctures as traditional remedies for mild indigestion, excessive sweating, and mouth, throat and minor skin inflammation, and it attaches clear limits⁸. The amount of thujone must be specified in each product and daily exposure kept below 6.0 mg; thujone is described as neurotoxic, so low-thujone plants should be preferred, and adequate tests of genotoxicity, carcinogenicity and reproductive toxicity have not been done. Use is not recommended under 18 years of age or during pregnancy and breastfeeding because data are lacking. No overdose from sage leaves has been reported, but sage oil corresponding to more than 15 g of leaf has caused heat, a racing heart, vertigo and epileptiform convulsions. A separate public statement concluded that the benefit-risk balance of sage essential oil taken as a medicine is negative, since its high thujone content risks exceeding the daily limit, and it set the 6.0 mg limit for sage-leaf preparations for up to 2 weeks⁹. Case reports bear out the seizure risk: a newborn and a toddler had generalized tonic-clonic seizures after accidental exposure to sage oil, with no other cause found, and both recovered¹⁰. Teas carry far less: Walch and colleagues found aqueous infusions recover on average 30% of the thujone that ethanol extraction yields, with average thujone contents of 4.4 mg/L in food teas and 11.3 mg/L in medicinal teas, and estimated that 3 to 6 cups a day could be drunk without reaching toxicological thresholds¹¹. None of these sources addresses epilepsy directly; the caution for people with epilepsy follows from thujone's convulsant effect.

Strength of evidence summary: Sage has unusually strong human clinical evidence for a culinary herb. Memory and cognition are supported by at least two double-blind randomized trials with consistent findings. Menopausal hot flash reduction is supported by one open trial and one meta-analysis of four RCTs — the evidence base is solid for frequency reduction though less conclusive for severity. Blood sugar effects are supported by one high-quality RCT and a confirmatory meta-analysis. The pharmacological mechanisms are well understood, lending biological plausibility to all three areas. The main research gaps are long-term safety data for sustained high-dose use and larger trials in each therapeutic area.